Syros Pharmaceuticals, a Cambridge, Mass.-based cancer drug developer, relied on Ten Bridge Communications and Stern IR for support through its July 6 IPO.
Syros raised $57.5M with the Nasdaq listing, short of projections. The funds will be used to fund its drug trials focused on controlling genes that cause cancer.
Ten Bridge partner Naoi Aoki leads the PR account at her firm, which was founded by Feinstein Kean Healthcare alums Dan Quinn and Ann Stanesa.
Stern senior associate Jesse Baumgartner reps Syros at the IR firm.
Joele Frank represents LXP Industrial Trust as the logistics giant agrees to be acquired by Brookfield Asset Management and the Canada Pension Plan Investment Trust for $5.2B in cash.
Jenn Kettnich, who has more than 15 years of financial communications experience, has joined Liftoff Mobile as VP-investor relations following completion of its recent IPO.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
